Skip to content

The Construction and Validation of a Self-Management Intervention Program for Patients with Acute Pancreatitis Based on the IKAP Theory

The Construction and Validation of a Self-Management Intervention Program for Patients with Acute Pancreatitis Based on the IKAP Theory

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108518
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

experimental group:A personalized guidance plan will be developed. Health education will be provided by doctors and primary nurses, specific plans will be formulated and summarized by researchers, and
control group:general nurse

Sponsors

The Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age>=18 years old; 2. Meet the diagnostic criteria for acute pancreatitis in the Chinese Guidelines for the Diagnosis and Treatment of Acute Pancreatitis (2023); 3. Speak freely and clearly, agree to participate in this study, and sign the informed consent form; 4. Have a high school education level or above.

Exclusion criteria

Exclusion criteria: 1. Those with other serious diseases, such as heart, liver, lung, kidney insufficiency and malignant tumors; 2. Pregnant or lactating; 3. Those with a history of mental illness or cognitive dysfunction; 4. There is a communication barrier that prevents the completion of this study.

Design outcomes

Primary

MeasureTime frame
self-care ability ;general self-efficacy;

Secondary

MeasureTime frame
Anxiety;

Countries

China

Contacts

Public ContactCheng Zhaohua

The Second Hospital of Jilin University

2238332758@qq.com+86 176 4313 6226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026